FDA: Opioids Plus Sedatives Pose Fatal Overdose Risk

September 12th, 2016

These drugs will now carry ‘boxed warning’ detailing the threat due to a review conducted by the FDA that identified a troubling trend in which patients are often prescribed these drugs in combination, even though they can interact in dangerous ways. Dr. Doug Throckmorton, deputy director of regulatory programs with the FDA’s Center for Drug Evaluation and Research stated, “We know approximately half of concurrent benzodiazepine and opioid analgesic prescriptions were dispensed to patients on the same day and prescribed by the same health care provider.”

Read More

Posted in Content

A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.